RecruitingPhase III🇵🇱 PolandEN original

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Pacjentki z nieoperacyjnym, zaawansowanym lub rozsianym rakiem piersi, który nie reaguje na hormony i nie ma przerostu HER2.
  • Rak piersi, który postępuje pomimo wcześniejszego leczenia hormonalnego, w tym z lekiem z grupy inhibitorów CDK4/6.
  • Pacjentki, które mogą przyjąć chemioterapię.
  • Ogólny stan zdrowia pozwalający na udział w badaniu (ocena ECOG 0-1).
  • Dobre funkcjonowanie narządów wewnętrznych.
  • Jeśli pacjentka choruje na HIV, wirus jest dobrze kontrolowany lekami.
  • Pacjentki z zapaleniem wątroby typu B lub C muszą mieć niewykrywalną ilość wirusa w badaniach.

✗ Disqualifies

  • Rak piersi, który można leczyć sposobem mającym na celu całkowite wyleczenie.
  • Rak piersi, który nawrócił krótko po leczeniu uzupełniającym (poniżej 6 miesięcy).
  • Objawy zaawansowanego raka, które mogą prowadzić do nagłych, groźnych dla życia powikłań.
  • Pacjentki, które wcześniej otrzymywały chemioterapię z powodu nieoperacyjnego, zaawansowanego lub rozsianego raka piersi.
  • Choroby autoimmunologiczne wymagające leczenia ogólnoustrojowego w ciągu ostatnich 2 lat.
  • Wcześniejsze zapalenie płuc wymagające sterydów lub aktualne zapalenie płuc.
  • Aktywne infekcje wymagające leczenia ogólnoustrojowego.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
June 29, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (259)

Ironwood Cancer & Research Centers ( Site 0066)

Chandler, United States

Banner MD Anderson Cancer Center-Oncology ( Site 0004)

Gilbert, United States

Providence Medical Foundation-Oncology ( Site 0020)

Fullerton, United States

Moores Cancer Center ( Site 0059)

La Jolla, United States

Cancer and Blood Specialty Clinic ( Site 0001)

Los Alamitos, United States

University of Colorado Anschutz Medical Campus ( Site 0061)

Aurora, United States

UCHealth Cherry Creek Medical Center ( Site 0094)

Denver, United States

University of Colorado Health - Highlands Ranch Hospital ( Site 0095)

Highlands Ranch, United States

Yale Cancer Center ( Site 0060)

New Haven, United States

Stamford Hospital ( Site 0049)

Stamford, United States

AdventHealth Altamonte Springs ( Site 0021)

Altamonte Springs, United States

University of Florida College of Medicine ( Site 0063)

Gainesville, United States

Orlando Health Cancer Institute ( Site 0011)

Orlando, United States

Archbold Memorial Hospital-Lewis Hall Singletary Oncology Center ( Site 0032)

Thomasville, United States

Rush University Medical Center ( Site 0079)

Chicago, United States

University of Chicago Medical Center ( Site 0067)

Chicago, United States

Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053)

Edgewood, United States

Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042)

Baton Rouge, United States

Greenebaum Comprehensive Cancer Center ( Site 0036)

Baltimore, United States

Mercy Medical Center - Baltimore-Medical Oncology and Hematology ( Site 0028)

Baltimore, United States

Holy Cross Hospital ( Site 0073)

Silver Spring, United States

Dana-Farber Cancer Institute-Breast Oncology Center ( Site 0037)

Boston, United States

Henry Ford Health ( Site 0002)

Detroit, United States

Saint Luke's Cancer Institute ( Site 0027)

Kansas City, United States

Washington University School of Medicine ( Site 0076)

St Louis, United States

NYU Langone Health - Brooklyn ( Site 0089)

Brooklyn, United States

NYU Langone Hospital - Long Island ( Site 0090)

Mineola, United States

Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068)

New York, United States

Hematology Oncology Associates of Rockland ( Site 0054)

Nyack, United States

Stony Brook University-Cancer Center ( Site 0034)

Stony Brook, United States

Levine Cancer Institute ( Site 0014)

Charlotte, United States

Zangmeister Cancer Center ( Site 7000)

Columbus, United States

Providence Portland Medical Center ( Site 0044)

Portland, United States

Providence St. Vincent Medical Center ( Site 0081)

Portland, United States

Thomas Jefferson University - Clinical Research Institute ( Site 0056)

Philadelphia, United States

Texas Oncology-Dallas Presbyterian Hospital ( Site 8000)

Dallas, United States

Parkland Health and Hospital System ( Site 0069)

Dallas, United States

UT Southwestern Medical Center ( Site 0050)

Dallas, United States

The Center for Cancer and Blood Disorders ( Site 0041)

Fort Worth, United States

Texas Oncology - San Antonio ( Site 8002)

San Antonio, United States

The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0057)

Tyler, United States

Inova Schar Cancer Institute ( Site 0025)

Fairfax, United States

Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015)

Midlothian, United States

VCU Health Adult Outpatient Pavillion ( Site 0070)

Richmond, United States

Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8001)

Roanoke, United States

University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0040)

Madison, United States

Instituto Alexander Fleming-Alexander Fleming ( Site 0382)

Buenos Aires, Argentina

Fundacion Estudios Clinicos-Oncology ( Site 0384)

Rosario, Argentina

Hospital Aleman-Oncology ( Site 0386)

Buenos Aires, Argentina

Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0383)

Buenos Aires, Argentina

Hospital Italiano de Córdoba ( Site 0385)

Córdoba, Argentina

Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0387)

La Rioja, Argentina

Macquarie University-MQ Health Clinical Trials Unit ( Site 2002)

Macquarie University, Australia

Westmead Hospital ( Site 2000)

Westmead, Australia

Frankston Hospital-Oncology and Haematology ( Site 2003)

Frankston, Australia

Fiona Stanley Hospital-Medical Oncology ( Site 2004)

Murdoch, Australia

Institut Jules Bordet-Medicine Oncology ( Site 1104)

Anderlecht, Belgium

Cliniques universitaires Saint-Luc-Medical Oncology ( Site 1103)

Brussels, Belgium

Jessa Ziekenhuis-Limburgs Oncologisch Centrum ( Site 1105)

Hasselt, Belgium

AZ Maria Middelares-IKG ( Site 1106)

Ghent, Belgium

Université Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 1107)

Namur, Belgium

Oncoclínica Oncologistas Associados-Clinical Research ( Site 0407)

Teresina, Brazil

Hospital Moinhos de Vento ( Site 0403)

Porto Alegre, Brazil

Hospital do Câncer Mãe de Deus ( Site 0404)

Porto Alegre, Brazil

Instituto de Oncologia Saint Gallen ( Site 0412)

Santa Cruz do Sul, Brazil

Instituto do Câncer Brasil - Unidade Taubaté ( Site 0408)

Taubaté, Brazil

IBCC - Núcleo de Pesquisa e Ensino ( Site 0401)

São Paulo, Brazil

BC Cancer Surrey ( Site 0315)

Surrey, Canada

Southlake Health ( Site 0311)

Newmarket, Canada

Princess Margaret Cancer Centre ( Site 0310)

Toronto, Canada

CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0301)

Montreal, Canada

Jewish General Hospital ( Site 0303)

Montreal, Canada

CHU de Quebec Universite Laval - Hopital du Saint-Sacrement ( Site 0302)

Québec, Canada

Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0308)

Rimouski, Canada

FALP-UIDO ( Site 0451)

Santiago, Chile

Oncovida ( Site 0453)

Santiago, Chile

Clínica RedSalud Vitacura ( Site 0455)

Santiago, Chile

Pontificia Universidad Catolica de Chile ( Site 0454)

Santiago, Chile

Bradfordhill ( Site 0452)

Santiago, Chile

Bradford Hill Norte ( Site 0456)

Antofagasta, Chile

Fundacion Colombiana de Cancerología Clinica Vida ( Site 0506)

Medellín, Colombia

FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0507)

Bogotá, Colombia

Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0501)

Valledupar, Colombia

IMAT S.A.S ( Site 0502)

Montería, Colombia

Fundación Valle del Lili ( Site 0508)

Cali, Colombia

CIMCA ( Site 0551)

San José, Costa Rica

Hospital Metropolitano - Sede Lindora ( Site 0550)

Santa Ana, Costa Rica

ICIMED ( Site 0552)

San José, Costa Rica

Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 1134)

Ostrava-Poruba, Czechia

Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1132)

Olomouc, Czechia

Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 1136)

Prague, Czechia

Nemocnice Ceske Budejovice-Onkologicke oddeleni ( Site 1138)

České Budějovice, Czechia

Fakultni nemocnice Kralovske Vinohrady-Onkologická klinika ( Site 1135)

Prague, Czechia

Rigshospitalet ( Site 1180)

Copenhagen, Denmark

Nordsjællands Hospital - Hillerød ( Site 1184)

Hillerød, Denmark

Næstved Sygehus ( Site 1182)

Næstved, Denmark

Odense Universitetshospital ( Site 1181)

Odense, Denmark

Vejle Sygehus ( Site 1183)

Vejle, Denmark

Hopital Prive Jean Mermoz-Oncology ( Site 1246)

Lyon, France

Centre François Baclesse ( Site 1250)

Caen, France

Centre de Cancérologie du Grand Montpellier ( Site 1244)

Montpellier, France

Hôpital privé du Confluent SAS-Service d'oncologie médicale ( Site 1242)

Nantes, France

Centre Hospitalier Universitaire de Poitiers-Pôle régional de cancérologie ( Site 1243)

Poitiers, France

Pitie Salpetriere University Hospital ( Site 1249)

Paris, France

Institut Curie-Oncology medical Department ( Site 1240)

Paris, France

Universitaetsklinikum Erlangen-Klinik für Gynäkologie und Geburtshilfe ( Site 1301)

Erlangen, Germany

Klinikum der Ludwig-Maximilians-Universitaet Muenchen-Frauenklinik Brustzentrum ( Site 1303)

München, Germany

Klinikum Ernst von Bergmann-Frauenklinik ( Site 1305)

Potsdam, Germany

Franziskus-Hospital Harderberg ( Site 1308)

Georgsmarienhütte, Germany

Universitaetsklinikum Duesseldorf-Klinik für Frauenheilkunde & Geburtshilfe ( Site 1311)

Düsseldorf, Germany

Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung-Klinik für Senologie/ Brustzentrum ( Site 1300)

Essen, Germany

CaritasKlinikum Saarbruecken St. Theresia ( Site 1304)

Saarbrücken, Germany

SRH Wald-Klinikum Gera-Zentrum für klinische Studien ( Site 1315)

Gera, Germany

Helios Klinikum Berlin-Buch-Klinik für Gynäkologie und Geburtshilfe ( Site 1314)

Berlin, Germany

Errikos Dunant Hospital Center ( Site 1348)

Athens, Greece

Aretaieio Hospital Oncology Unit ( Site 1345)

Athens, Greece

Hygeia Hospital ( Site 1346)

Marousi, Greece

University General Hospital of Larissa ( Site 1343)

Larissa, Greece

European Interbalkan Medical Center ( Site 1347)

Thessaloniki, Greece

European Interbalkan Medical Center ( Site 1341)

Thessaloniki, Greece

Queen Mary Hospital ( Site 2040)

Hksar, Hong Kong

Prince of Wales Hospital ( Site 2041)

Shatin, Hong Kong

Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Onkoterápiás Klinika ( Site 1379)

Szeged, Hungary

Somogy Vármegyei Kaposi Mór Oktató Kórház-Oncology center ( Site 1371)

Kaposvár, Hungary

Zala Vármegyei Szent Rafael Kórház-Onkológiai osztály ( Site 1372)

Zalaegerszeg, Hungary

Semmelweis Egyetem-Belgyógyászati és Onkológiai Klinika ( Site 1381)

Budapest, Hungary

Budapesti Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 1373)

Budapest, Hungary

Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 1375)

Debrecen, Hungary

Tata Memorial Hospital-Medical Oncology ( Site 2053)

Mumbai, India

Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute-Centre for cancer ( Site 2056)

Mumbai, India

All India Institute of Medical Sciences ( Site 2051)

New Delhi, India

Rajiv Gandhi Cancer Institute And Research Centre-Department of Clinical Research ( Site 2052)

New Delhi, India

Bon Secours Cork Hospital ( Site 1422)

Cork, Ireland

St. Vincent's University Hospital-Medical Oncology Research Department ( Site 1420)

Dublin, Ireland

Mater Misericordiae University Hospital-Clinical Trials Research Unit ( Site 1423)

Dublin, Ireland

Rambam Health Care Campus-Oncology Division ( Site 1452)

Haifa, Israel

Hadassah Medical Center ( Site 1451)

Jerusalem, Israel

Rabin Medical Center ( Site 1453)

Petah Tikva, Israel

Sheba Medical Center ( Site 1450)

Ramat Gan, Israel

IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 1480)

Meldola, Italy

CRO-IRCCS ( Site 1478)

Aviano, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1472)

Milan, Italy

Istituto Europeo di Oncologia IRCCS-Divisione di Senologia Medica ( Site 1475)

Milan, Italy

Istituto Clinico Humanitas ( Site 1476)

Rozzano, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1474)

Bologna, Italy

Ospedale San Martino ( Site 1479)

Genova, Italy

Ospedale San Raffaele-Oncologia Medica ( Site 1471)

Milan, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1477)

Roma, Italy

Nagoya City University Hospital ( Site 2474)

Nagoya, Japan

National Cancer Center Hospital East ( Site 2463)

Kashiwa, Japan

Hokkaido University Hospital ( Site 2460)

Sapporo, Japan

Tokai University Hospital ( Site 2473)

Isehara, Japan

St. Marianna University Hospital ( Site 2465)

Kawasaki, Japan

Kitasato University Hospital ( Site 2471)

Sagamihara, Japan

Kanagawa Cancer Center ( Site 2472)

Yokohama, Japan

Mie University Hospital ( Site 2483)

Tsu, Japan

Tohoku University Hospital ( Site 2482)

Sendai, Japan

The University of Osaka Hospital ( Site 2476)

Suita, Japan

Saitama Medical University International Medical Center ( Site 2462)

Hidaka, Japan

Juntendo University Hospital ( Site 2468)

Bunkyo, Japan

Cancer Institute Hospital of JFCR ( Site 2464)

Koto, Japan

Showa Medical University Hospital ( Site 2466)

Shinagawa, Japan

Tokyo Medical University Hospital ( Site 2467)

Shinjuku, Japan

National Center for Global Health and Medicine ( Site 2469)

Shinjuku, Japan

Fukushima Medical University Hospital ( Site 2461)

Fukushima, Japan

Gifu University Hospital ( Site 2486)

Gifu, Japan

Hiroshima City Hiroshima Citizens Hospital ( Site 2478)

Hiroshima, Japan

Social medical corporation Hakuaikai Sagara Hospital ( Site 2481)

Kagoshima, Japan

Kumamoto University Hospital ( Site 2480)

Kumamoto, Japan

Kyoto University Hospital ( Site 2475)

Kyoto, Japan

Okayama University Hospital ( Site 2485)

Okayama, Japan

Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 2477)

Osaka, Japan

Hospital Sultan Ismail ( Site 2153)

Johor Bahru, Malaysia

Sarawak General Hospital ( Site 2154)

Kuching, Malaysia

Pantai Hospital Kuala Lumpur ( Site 2151)

Kuala Lumpur, Malaysia

CIO - Centro de Inmuno-Oncología de Occidente ( Site 0592)

Guadalajara, Mexico

Grupo Médico ASSET-Clinical Research ( Site 0596)

Mexico City, Mexico

Health Pharma Professional Research S.A. de C.V: ( Site 0598)

Mexico City, Mexico

INCAN-TUMORES MAMARIOS ( Site 0597)

Mexico City, Mexico

Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0590)

Monterrey, Mexico

CENTRO MEDICO ZAMBRANO HELLION-Centro de Cáncer de Mama ( Site 0595)

San Pedro Garza García, Mexico

Ziekenhuis Rijnstate-Rijnstate Centrum Oncologisch Onderzoek ( Site 1524)

Arnhem, Netherlands

Maastricht UMC+-Medical Oncology ( Site 1522)

Maastricht, Netherlands

Amphia Ziekenhuis, locatie Breda Molengracht-oncologie ( Site 1523)

Breda, Netherlands

Catharina Ziekenhuis ( Site 1526)

Eindhoven, Netherlands

Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL)-medical oncology ( Site 1520)

Amsterdam, Netherlands

Isala, locatie Zwolle ( Site 1525)

Zwolle, Netherlands

Meander Medisch Centrum ( Site 1521)

Amersfoort, Netherlands

Auckland City Hospital ( Site 2031)

Auckland, New Zealand

Clinica Vallesur - AUNA ( Site 0652)

Arequipa, Peru

Hospital Militar Central Luis Arias Schereiber ( Site 0651)

Jesús María, Peru

Oncosalud ( Site 0650)

Lima, Peru

IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0653)

Lima, Peru

Metro Davao Medical and Research Center ( Site 2202)

Davao City, Philippines

ST. LUKE'S MEDICAL CENTER-Medicine ( Site 2200)

Quezon City, Philippines

Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1582)

Bydgoszcz, Poland

Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1584)

Siedlce, Poland

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Piersi i Chirurgii ( Site 1580)

Warsaw, Poland

Mazowiecki Szpital Onkologiczny ( Site 1581)

Wieliszew, Poland

Mrukmed-Mrukmed ( Site 1592)

Rzeszów, Poland

Bialostockie Centrum Onkologii ( Site 1585)

Bialystok, Poland

Szpitale Pomorskie Sp. z o. o.-Oddział Onkologii Klinicznej ( Site 1593)

Gdynia, Poland

Narodowy Instytut Onkologii - Oddzial w Gliwicach-Centrum Diagnostyki i Leczenia Chorob Piersi ( Site 1590)

Gliwice, Poland

Szpital Wojewódzki w Koszalinie. ( Site 1583)

Poland, Poland

Zachodniopomorskie Centrum Onkologii ( Site 1588)

Szczecin, Poland

Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 1595)

Kielce, Poland

Unidade Local de Saude Amadora/Sintra - Hospital Prof Dr Fernando Fonseca ( Site 1663)

Lisbon, Portugal

Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 1661)

Lisbon, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 1662)

Porto, Portugal

Puerto Rico Medical Research Center LLC ( Site 0675)

Hato Rey, Puerto Rico

UPR Comprehensive Cancer Center-Comprehensive Cancer Center Hospital ( Site 0677)

San Juan, Puerto Rico

Spitalul Clinic Filantropia ( Site 1703)

Bucharest, Romania

SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 1702)

Florești, Romania

Centrul Medical Neolife- Baneasa ( Site 1704)

Bucharest, Romania

Institutul Oncologic Cluj ( Site 1701)

Cluj-Napoca, Romania

National University Hospital ( Site 2250)

Singapore, Singapore

Mount Alvernia ICON Cancer Center ( Site 2251)

Singapore, Singapore

CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 2905)

Port Elizabeth, South Africa

Wits Clinical Research ( Site 2903)

Johannesburg, South Africa

Curo Oncology ( Site 2908)

Pretoria, South Africa

Sandton Oncology Medical Group (Pty) Ltd ( Site 2911)

Sandton, South Africa

Cancercare Rondebosch Oncology-Clinical trials ( Site 2904)

Cape Town, South Africa

Seoul National University Hospital-Internal Medicine ( Site 2353)

Seoul, South Korea

Severance Hospital, Yonsei University Health System-Medical oncology ( Site 2350)

Seoul, South Korea

Asan Medical Center-Department of Oncology ( Site 2352)

Seoul, South Korea

Samsung Medical Center-Division of Hematology/Oncology ( Site 2351)

Seoul, South Korea

HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1758)

Pozuelo de Alarcón, Spain

HOSPITAL CLINICO DE VALENCIA-Oncology ( Site 1752)

Valencia, Spain

Hospital Universitari Vall d'Hebron-Oncology ( Site 1750)

Barcelona, Spain

Hospital Universitario Reina Sofia-Oncologia Medica ( Site 1754)

Córdoba, Spain

Hospital Beata María Ana-oncology ( Site 1755)

Madrid, Spain

HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 1756)

Madrid, Spain

Hospital Universitario Virgen Macarena ( Site 1757)

Seville, Spain

Karolinska Universitetssjukhuset Solna ( Site 1801)

Stockholm, Sweden

Akademiska sjukhuset ( Site 1802)

Uppsala, Sweden

Södra Älvsborgs Sjukhus Borås ( Site 1803)

Borås, Sweden

University Hospital Basel-Gynecology & Gynecologic Oncology ( Site 1844)

Basel, Switzerland

Spital Thun ( Site 1840)

Thun, Switzerland

Brust-Zentrum ( Site 1841)

Zurich, Switzerland

Changhua Christian Hospital ( Site 2410)

Changhua, Taiwan

Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 2413)

Kaohsiung City, Taiwan

National Cheng Kung University Hospital-Surgery ( Site 2411)

Tainan, Taiwan

National Taiwan University Hospital-Oncology ( Site 2415)

Taipei, Taiwan

Mackay Memorial Hospital ( Site 2412)

Taipei, Taiwan

Chang Gung Medical Foundation-Linkou Branch-General Surgery ( Site 2414)

Taoyuan, Taiwan

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi ( Site 1878)

Yenimahalle, Turkey (Türkiye)

Medipol Mega Universite Hastanesi-oncology ( Site 1875)

Stanbul, Turkey (Türkiye)

Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 1876)

Adana, Turkey (Türkiye)

Hacettepe Universite Hastaneleri-oncology hospital ( Site 1870)

Ankara, Turkey (Türkiye)

Memorial Ankara Hastanesi-Medical Oncology ( Site 1874)

Ankara, Turkey (Türkiye)

Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1871)

Ankara, Turkey (Türkiye)

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1872)

Istanbul, Turkey (Türkiye)

Samsun Medical Park Hastanesi-medical oncology ( Site 1873)

Samsun, Turkey (Türkiye)

North West Cancer Centre ( Site 1944)

Londonderry, United Kingdom

The Royal Cornwall Hospital ( Site 1943)

Truro, United Kingdom

St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 1940)

London, United Kingdom

University College London Hospital-Cancer Clinical Trials Unit ( Site 1942)

London, United Kingdom

Blackpool Victoria Hospital ( Site 1941)

Blackpool, United Kingdom

City Hospital, Nottingham University Hospitals NHS Trust ( Site 1945)

Nottingham, United Kingdom

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.